Smart Money · Holder IQ
74.7 / 100
Above median holder quality (percentile 65.2 this quarter).
AIM
AIM ImmunoTech IncAMEX
$0.15+0.13%
Close Nov 12, 2026
Reading stored signals…
Healthcare • Biotechnology
People-network credibilityUncalibrated
No reporting owner has a RED or GREEN connection distinguishable from zero in this publication.
Show all 2 reporting owners
- David I. ChemerowDirector — as filedRED 0 · GREEN 0 · Net 0
- Thomas K. EquelsCEO & President · Director — as filedRED 0 · GREEN 0 · Net 0
How this is measured
A connection is distinguishable from zero here only when its RED or GREEN published interval has a lower bound above zero. A person with an admitted finding is always listed first, even with a zero score. Connections are then ordered by the larger of RED and GREEN. A zero tied with other owners is not given a percentile.
RED measures graph connections to people with admitted adjudications; GREEN measures connections to repeat value creators and stewards of qualifying compounders and long-term shareholder-return leaders. Net is GREEN minus RED on a −1 to 1 scale, not a probability or expected return. Connections alone do not establish conduct. These measures are separate from insider trading performance and Company Quality Grade.
The publication is uncalibrated. Its intervals are published bands, not a claim of calibrated confidence or a tested forecast.
Admitted findings are published guilty pleas, convictions and litigated SEC judgments or orders. Settlements and open cases are not findings. A positive net does not erase an admitted finding. Absence of a finding is not a clearance or a complete regulatory-history search.
Reporting owners who filed from after Oct 9, 2025 through Oct 9, 2026: a 12-month window ending at the publication date. This can include former officers and directors; it is not a verified roster of today's employees.
Link an account to see your stake, watchlist and past holdings. use the cited filings to check the reported role and evidence alongside your investment thesis. A connection alone does not tell you to increase or reduce a holding.
Medians across all 2 scored reporting owners at this company as of Oct 9, 2026: RED 0, GREEN 0, net 0. Highest RED: 0; highest GREEN: 0.
- Issuer CIK
- 0000946644
- Publication as of
- Oct 9, 2026; known by Oct 9, 2026
- Retrieved
- Nov 13, 2026; a new publication can take up to six hours to appear here
- RED source refresh state
- fresh within 8d
- Method
- epg.signed_credibility.raw-uncalibrated.v1
- Population identity
- sha256:733e7e30f755f296f1d478ccb2c8674cb0adf04ebbe89319e08bc8255dddb9c5
- Graph identity
- c6521b138848011b775d9a6dfb7ac59989b2082fdc729ef4f41456a4e2037f60
- Source
- SEC Forms 3, 4 and 5 for roles; the Midas Edge API's active immutable people-network publication for credibility and admitted findings. GREEN seed evidence can include vendor price histories. No portfolio or account data is sent to this product.
David I. Chemerow · SEC CIK 0001193743
Read the Form 4 filed Mar 16, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: e98de2335be672298b7a82d13f383f6ebe1eb3a980d918ab1a43cdb0d64973d9
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Thomas K. Equels · SEC CIK 0001450324
Read the Form 4 filed Sep 18, 2026Published intervals: RED 0 to 0.02; GREEN 0 to 0.02; net -0.04 to 0.04.
Score identity: 69f17241267c9b6008c0edf5b5a9a7667822ee2525c165749d08374530020de4
Calibration versions: RED affine-identity-unfitted.v1; GREEN affine-identity-unfitted.v1
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
- Market cap
- $5.93M
- 1 month
- -8.2%
- 3 months
- -32.4%
- 1 year
- -90.6%
More market facts
- Dividend
- No dividends on record
- Short interest
- 3.6% of float1M shares · settled Oct 30, 2026 · -7.2% since Oct 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $95K
- Net income
- -$14.27M
- Free cash flow
- -$7.16M
- Book value
- $7.74M
- Total debt
- $3.92M
- P/E
- —
- Price / sales
- 62.4×
- Price / book
- 0.8×
- FCF yield
- -120.8%
- Net margin
- -15,021.1%
Trailing twelve-month statements · as of Nov 12, 2026
End-of-day close from stored market data, not a live quote.
About AIM ImmunoTech Inc
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
Read more
The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.
- Website
- aimimmuno.com
- Headquarters
- Ocala, FL, United States
- Employees
- 19
- Listed
- Jul 12, 1996
- Fiscal year ends
- December
Company profile stored Oct 25, 2026.
Quarterly results
The last 8 fiscal quarters from the latest stored normalized financial statements. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 7, 2026 | $26.0K | +4.0% | 80.8% | -$3.5M | -$3.8M |
| Mar 2026filed May 15, 2026 | $22.0K | +37.5% | -113.6% | -$2.2M | -$3.0M |
| Dec 2025filed Mar 27, 2026 | $21.0K | -53.3% | -90.5% | -$3.0M | -$4.2M |
| Sep 2025filed Nov 17, 2025 | $26.0K | -25.7% | -369.2% | -$2.4M | -$3.3M |
| Jun 2025filed Aug 14, 2025 | $25.0K | -50.0% | 60.0% | -$2.6M | -$2.8M |
| Mar 2025filed May 15, 2025 | $16.0K | -60.0% | 37.5% | -$3.6M | -$3.7M |
| Dec 2024filed Mar 27, 2025 | $45.0K | -30.8% | — | -$5.9M | -$6.0M |
| Sep 2024filed Nov 14, 2024 | $35.0K | — | 77.1% | -$4.5M | -$3.7M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $9.9M
- Reported total debt
- $3.9M
- Current assets
- $10.4M
- Current liabilities
- $4.9M
Vendor filing date:
As of
- Reported cash
- $5.8M
- Reported total debt
- $4.6M
- Current assets
- $6.2M
- Current liabilities
- $6.1M
Vendor filing date:
As of
- Reported cash
- $931.0K
- Reported total debt
- $4.9M
- Current assets
- $3.3M
- Current liabilities
- $6.2M
Vendor filing date:
As of
- Reported cash
- $2.3M
- Reported total debt
- $2.3M
- Current assets
- $2.6M
- Current liabilities
- $4.0M
Vendor filing date:
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: the latest stored normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Mar 27, 2026 | $88.0K | -48.2% | -284.1% | -$10.5M | -$14.0M |
| Dec 2024filed Mar 27, 2025 | $170.0K | -15.8% | 81.8% | -$19.8M | -$17.3M |
| Dec 2023filed Apr 1, 2024 | $202.0K | +43.3% | 79.2% | -$31.9M | -$29.0M |
| Dec 2022filed Mar 31, 2023 | $141.0K | +4.4% | — | -$19.9M | -$19.4M |
| Dec 2021filed Mar 31, 2022 | $135.0K | -17.2% | -529.6% | -$18.8M | -$19.1M |
| Dec 2020filed Mar 31, 2021 | $163.0K | +16.4% | -394.5% | -$15.2M | -$14.4M |
Annual cash generation
Does profit turn into cash? Compare AIM’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$14.0M
- Operating cash flow
- -$11.0M
- Capital spending
- $378.0K
- Free cash flow
- -$11.3M
Fiscal year ending
- Net income
- -$17.3M
- Operating cash flow
- -$14.9M
- Capital spending
- $18.0K
- Free cash flow
- -$14.9M
Fiscal year ending
- Net income
- -$29.0M
- Operating cash flow
- -$21.3M
- Capital spending
- $585.0K
- Free cash flow
- -$21.9M
Earlier cash-flow years
Fiscal year ending
- Net income
- -$19.4M
- Operating cash flow
- -$16.1M
- Capital spending
- $271.0K
- Free cash flow
- -$16.4M
Fiscal year ending
- Net income
- -$19.1M
- Operating cash flow
- -$14.0M
- Capital spending
- $41.0K
- Free cash flow
- -$14.0M
Fiscal year ending
- Net income
- -$14.4M
- Operating cash flow
- -$10.4M
- Capital spending
- $595.0K
- Free cash flow
- -$11.0M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: Annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did AIM’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $8.3M
- Net borrowing / repayment
- $2.1M
- Total financing cash flow
- $10.4M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $4.2M
- Net borrowing / repayment
- $2.2M
- Total financing cash flow
- $6.4M
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $485.0K
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $485.0K
Fiscal year ended
Vendor filing date:
- Net share issuance / purchases
- $80.0K
- Net borrowing / repayment
- $0.0
- Total financing cash flow
- $80.0K
Fiscal year ended
Vendor filing date:
- Net borrowing / repayment
- -$4.9M
- Total financing cash flow
- $8.2M
Fiscal year ended
Vendor filing date:
- Total financing cash flow
- $56.6M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: Annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Short-interest history
Reported short positions, stored float percentages and adjusted prices over the same period.
Shares short
Share of float
Adjusted close · USD
Settlement records · 132 observations
Settlement Oct 30, 2026
1,002,082 shares short
-77,807 shares (-7.2%) vs Oct 15, 2026
3.6% of the stored float. Published Nov 10, 2026.
Settlement Oct 15, 2026
1,079,889 shares short
-327,309 shares (-23.3%) vs Sep 30, 2026
3.9% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
1,407,198 shares short
-1,357,989 shares (-49.1%) vs Sep 15, 2026
5.1% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,765,187 shares short
+2,192,605 shares (+382.9%) vs Aug 31, 2026
21.7% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
572,582 shares short
-118,952 shares (-17.2%) vs Aug 14, 2026
Published Sep 10, 2026.
Settlement Aug 14, 2026
691,534 shares short
-222,358 shares (-24.3%) vs Jul 31, 2026
Published Aug 25, 2026.
Settlement Jul 31, 2026
913,892 shares short
-629,934 shares (-40.8%) vs Jul 15, 2026
Published Aug 11, 2026.
Settlement Jul 15, 2026
1,543,826 shares short
-657,810 shares (-29.9%) vs Jun 30, 2026
Published Jul 24, 2026.
Settlement Jun 30, 2026
2,201,636 shares short
-1,002,456 shares (-31.3%) vs Jun 15, 2026
Published Jul 10, 2026.
Settlement Jun 15, 2026
3,204,092 shares short
-3,809,251 shares (-54.3%) vs May 29, 2026
Published Jun 25, 2026.
Settlement May 29, 2026
7,013,343 shares short
+6,876,265 shares (+5,016.3%) vs May 15, 2026
Published Jun 9, 2026.
Settlement May 15, 2026
137,078 shares short
-166,087 shares (-54.8%) vs Apr 30, 2026
Published May 27, 2026.
Settlement Apr 30, 2026
303,165 shares short
+54,534 shares (+21.9%) vs Apr 15, 2026
Published May 11, 2026.
Settlement Apr 15, 2026
248,631 shares short
+88,912 shares (+55.7%) vs Mar 31, 2026
Published Apr 24, 2026.
Settlement Mar 31, 2026
159,719 shares short
+6,455 shares (+4.2%) vs Mar 13, 2026
Published Apr 10, 2026.
Settlement Mar 13, 2026
153,264 shares short
+58,674 shares (+62%) vs Feb 27, 2026
Published Mar 24, 2026.
Settlement Feb 27, 2026
94,590 shares short
-48,312 shares (-33.8%) vs Feb 13, 2026
Published Mar 10, 2026.
Settlement Feb 13, 2026
142,902 shares short
Published Feb 25, 2026.
Settlement Jan 30, 2026
328,268 shares short
+266,314 shares (+429.9%) vs Jan 15, 2026
Published Feb 10, 2026.
Settlement Jan 15, 2026
61,954 shares short
-143,939 shares (-69.9%) vs Dec 31, 2025
Published Jan 27, 2026.
Settlement Dec 31, 2025
205,893 shares short
+178,861 shares (+661.7%) vs Dec 15, 2025
Published Jan 12, 2026.
Settlement Dec 15, 2025
27,032 shares short
+13,855 shares (+105.1%) vs Nov 28, 2025
Published Dec 24, 2025.
Settlement Nov 28, 2025
13,177 shares short
+6,264 shares (+90.6%) vs Nov 14, 2025
Published Dec 9, 2025.
Settlement Nov 14, 2025
6,913 shares short
-22,118 shares (-76.2%) vs Oct 31, 2025
Published Nov 25, 2025.
Settlement Oct 31, 2025
29,031 shares short
-15,770 shares (-35.2%) vs Oct 15, 2025
Published Nov 11, 2025.
Settlement Oct 15, 2025
44,801 shares short
-9,665 shares (-17.7%) vs Sep 30, 2025
Published Oct 24, 2025.
Settlement Sep 30, 2025
54,466 shares short
+46,318 shares (+568.5%) vs Sep 15, 2025
Published Oct 9, 2025.
Settlement Sep 15, 2025
8,148 shares short
-29,238 shares (-78.2%) vs Aug 29, 2025
Published Sep 24, 2025.
Settlement Aug 29, 2025
37,386 shares short
+3,567 shares (+10.5%) vs Aug 15, 2025
Published Sep 10, 2025.
Settlement Aug 15, 2025
33,819 shares short
-40,039 shares (-54.2%) vs Jul 31, 2025
Published Aug 26, 2025.
Settlement Jul 31, 2025
73,858 shares short
+65,682 shares (+803.4%) vs Jul 15, 2025
Published Aug 11, 2025.
Settlement Jul 15, 2025
8,176 shares short
-1,465 shares (-15.2%) vs Jun 30, 2025
Published Jul 24, 2025.
Settlement Jun 30, 2025
9,641 shares short
Published Jul 10, 2025.
Settlement Mar 31, 2025
3,004,348 shares short
-168,051 shares (-5.3%) vs Mar 14, 2025
Published Apr 9, 2025.
Settlement Mar 14, 2025
3,172,399 shares short
-112,646 shares (-3.4%) vs Feb 28, 2025
Published Mar 25, 2025.
Settlement Feb 28, 2025
3,285,045 shares short
-127,375 shares (-3.7%) vs Feb 14, 2025
Published Mar 11, 2025.
Settlement Feb 14, 2025
3,412,420 shares short
+2,497,604 shares (+273%) vs Jan 31, 2025
Published Feb 26, 2025.
Settlement Jan 31, 2025
914,816 shares short
+282,629 shares (+44.7%) vs Jan 15, 2025
Published Feb 11, 2025.
Settlement Jan 15, 2025
632,187 shares short
+116,473 shares (+22.6%) vs Dec 31, 2024
Published Jan 27, 2025.
Settlement Dec 31, 2024
515,714 shares short
+3,390 shares (+0.7%) vs Dec 13, 2024
Published Jan 10, 2025.
Settlement Dec 13, 2024
512,324 shares short
-110,036 shares (-17.7%) vs Nov 29, 2024
Published Dec 24, 2024.
Settlement Nov 29, 2024
622,360 shares short
+94,018 shares (+17.8%) vs Nov 15, 2024
Published Dec 10, 2024.
Settlement Nov 15, 2024
528,342 shares short
+36,968 shares (+7.5%) vs Oct 31, 2024
Published Nov 26, 2024.
Settlement Oct 31, 2024
491,374 shares short
-18,558 shares (-3.6%) vs Oct 15, 2024
Published Nov 11, 2024.
Settlement Oct 15, 2024
509,932 shares short
-80,397 shares (-13.6%) vs Sep 30, 2024
Published Oct 24, 2024.
Settlement Sep 30, 2024
590,329 shares short
+92,250 shares (+18.5%) vs Sep 13, 2024
Published Oct 9, 2024.
Settlement Sep 13, 2024
498,079 shares short
-22,123 shares (-4.3%) vs Aug 30, 2024
Published Sep 24, 2024.
Settlement Aug 30, 2024
520,202 shares short
-49,756 shares (-8.7%) vs Aug 15, 2024
Published Sep 11, 2024.
Settlement Aug 15, 2024
569,958 shares short
-58,757 shares (-9.3%) vs Jul 31, 2024
Published Aug 26, 2024.
Settlement Jul 31, 2024
628,715 shares short
+167,052 shares (+36.2%) vs Jul 15, 2024
Published Aug 9, 2024.
Settlement Jul 15, 2024
461,663 shares short
-42 shares (0%) vs Jun 28, 2024
Published Jul 24, 2024.
Settlement Jun 28, 2024
461,705 shares short
-47,882 shares (-9.4%) vs Jun 14, 2024
Published Jul 10, 2024.
Settlement Jun 14, 2024
509,587 shares short
+90,198 shares (+21.5%) vs May 31, 2024
Published Jun 26, 2024.
Settlement May 31, 2024
419,389 shares short
-13,805 shares (-3.2%) vs May 15, 2024
Published Jun 11, 2024.
Settlement May 15, 2024
433,194 shares short
+11,509 shares (+2.7%) vs Apr 30, 2024
Published May 24, 2024.
Settlement Apr 30, 2024
421,685 shares short
-55,491 shares (-11.6%) vs Apr 15, 2024
Published May 9, 2024.
Settlement Apr 15, 2024
477,176 shares short
-15,143 shares (-3.1%) vs Mar 28, 2024
Published Apr 24, 2024.
Settlement Mar 28, 2024
492,319 shares short
+65,269 shares (+15.3%) vs Mar 15, 2024
Published Apr 9, 2024.
Settlement Mar 15, 2024
427,050 shares short
+15,183 shares (+3.7%) vs Feb 29, 2024
Published Mar 26, 2024.
Settlement Feb 29, 2024
411,867 shares short
-22,213 shares (-5.1%) vs Feb 15, 2024
Published Mar 11, 2024.
Settlement Feb 15, 2024
434,080 shares short
+50,744 shares (+13.2%) vs Jan 31, 2024
Published Feb 27, 2024.
Settlement Jan 31, 2024
383,336 shares short
-763 shares (-0.2%) vs Jan 12, 2024
Published Feb 9, 2024.
Settlement Jan 12, 2024
384,099 shares short
+11,612 shares (+3.1%) vs Dec 29, 2023
Published Jan 24, 2024.
Settlement Dec 29, 2023
372,487 shares short
-53,816 shares (-12.6%) vs Dec 15, 2023
Published Jan 10, 2024.
Settlement Dec 15, 2023
426,303 shares short
-13,353 shares (-3%) vs Nov 30, 2023
Published Dec 26, 2023.
Settlement Nov 30, 2023
439,656 shares short
-23,295 shares (-5%) vs Nov 15, 2023
Published Dec 11, 2023.
Settlement Nov 15, 2023
462,951 shares short
+17,131 shares (+3.8%) vs Oct 31, 2023
Published Nov 24, 2023.
Settlement Oct 31, 2023
445,820 shares short
+1,819 shares (+0.4%) vs Oct 13, 2023
Published Nov 9, 2023.
Settlement Oct 13, 2023
444,001 shares short
+20,787 shares (+4.9%) vs Sep 29, 2023
Published Oct 24, 2023.
Settlement Sep 29, 2023
423,214 shares short
-59,296 shares (-12.3%) vs Sep 15, 2023
Published Oct 10, 2023.
Settlement Sep 15, 2023
482,510 shares short
-9,307 shares (-1.9%) vs Aug 31, 2023
Published Sep 26, 2023.
Settlement Aug 31, 2023
491,817 shares short
-112,506 shares (-18.6%) vs Aug 15, 2023
Published Sep 11, 2023.
Settlement Aug 15, 2023
604,323 shares short
+40,085 shares (+7.1%) vs Jul 31, 2023
Published Aug 24, 2023.
Settlement Jul 31, 2023
564,238 shares short
-75,524 shares (-11.8%) vs Jul 14, 2023
Published Aug 9, 2023.
Settlement Jul 14, 2023
639,762 shares short
-32,494 shares (-4.8%) vs Jun 30, 2023
Published Jul 25, 2023.
Settlement Jun 30, 2023
672,256 shares short
-18,953 shares (-2.7%) vs Jun 15, 2023
Published Jul 11, 2023.
Settlement Jun 15, 2023
691,209 shares short
-15,709 shares (-2.2%) vs May 31, 2023
Published Jun 26, 2023.
Settlement May 31, 2023
706,918 shares short
-13,252 shares (-1.8%) vs May 15, 2023
Published Jun 9, 2023.
Settlement May 15, 2023
720,170 shares short
-47,282 shares (-6.2%) vs Apr 28, 2023
Published May 24, 2023.
Settlement Apr 28, 2023
767,452 shares short
-70,666 shares (-8.4%) vs Apr 14, 2023
Published May 9, 2023.
Settlement Apr 14, 2023
838,118 shares short
-32,559 shares (-3.7%) vs Mar 31, 2023
Published Apr 25, 2023.
Settlement Mar 31, 2023
870,677 shares short
-8,258 shares (-0.9%) vs Mar 15, 2023
Published Apr 11, 2023.
Settlement Mar 15, 2023
878,935 shares short
+40,181 shares (+4.8%) vs Feb 28, 2023
Published Mar 24, 2023.
Settlement Feb 28, 2023
838,754 shares short
-55,006 shares (-6.2%) vs Feb 15, 2023
Published Mar 9, 2023.
Settlement Feb 15, 2023
893,760 shares short
+70,128 shares (+8.5%) vs Jan 31, 2023
Published Feb 24, 2023.
Settlement Jan 31, 2023
823,632 shares short
+266,500 shares (+47.8%) vs Jan 13, 2023
Published Feb 9, 2023.
Settlement Jan 13, 2023
557,132 shares short
+11,677 shares (+2.1%) vs Dec 30, 2022
Published Jan 24, 2023.
Settlement Dec 30, 2022
545,455 shares short
+7,477 shares (+1.4%) vs Dec 15, 2022
Published Jan 10, 2023.
Settlement Dec 15, 2022
537,978 shares short
+14,869 shares (+2.8%) vs Nov 30, 2022
Published Dec 26, 2022.
Settlement Nov 30, 2022
523,109 shares short
-39,383 shares (-7%) vs Nov 15, 2022
Published Dec 9, 2022.
Settlement Nov 15, 2022
562,492 shares short
+6,181 shares (+1.1%) vs Oct 31, 2022
Published Nov 24, 2022.
Settlement Oct 31, 2022
556,311 shares short
-23,320 shares (-4%) vs Oct 14, 2022
Published Nov 9, 2022.
Settlement Oct 14, 2022
579,631 shares short
+37,376 shares (+6.9%) vs Sep 30, 2022
Published Oct 25, 2022.
Settlement Sep 30, 2022
542,255 shares short
-4,958 shares (-0.9%) vs Sep 15, 2022
Published Oct 11, 2022.
Settlement Sep 15, 2022
547,213 shares short
-1,962 shares (-0.4%) vs Aug 31, 2022
Published Sep 26, 2022.
Settlement Aug 31, 2022
549,175 shares short
-32,619 shares (-5.6%) vs Aug 15, 2022
Published Sep 9, 2022.
Settlement Aug 15, 2022
581,794 shares short
-35,068 shares (-5.7%) vs Jul 29, 2022
Published Aug 24, 2022.
Settlement Jul 29, 2022
616,862 shares short
+66,369 shares (+12.1%) vs Jul 15, 2022
Published Aug 9, 2022.
Settlement Jul 15, 2022
550,493 shares short
-41,572 shares (-7%) vs Jun 30, 2022
Published Jul 26, 2022.
Settlement Jun 30, 2022
592,065 shares short
+11,622 shares (+2%) vs Jun 15, 2022
Published Jul 11, 2022.
Settlement Jun 15, 2022
580,443 shares short
+16,323 shares (+2.9%) vs May 31, 2022
Published Jun 24, 2022.
Settlement May 31, 2022
564,120 shares short
-118,355 shares (-17.3%) vs May 13, 2022
Published Jun 9, 2022.
Settlement May 13, 2022
682,475 shares short
-237,787 shares (-25.8%) vs Apr 29, 2022
Published May 24, 2022.
Settlement Apr 29, 2022
920,262 shares short
+310,860 shares (+51%) vs Mar 31, 2022
Published May 10, 2022.
Settlement Mar 31, 2022
609,402 shares short
-48,675 shares (-7.4%) vs Mar 15, 2022
Published Apr 11, 2022.
Settlement Mar 15, 2022
658,077 shares short
-21,512 shares (-3.2%) vs Feb 28, 2022
Published Mar 24, 2022.
Settlement Feb 28, 2022
679,589 shares short
+42,582 shares (+6.7%) vs Feb 15, 2022
Published Mar 9, 2022.
Settlement Feb 15, 2022
637,007 shares short
-13,277 shares (-2%) vs Jan 31, 2022
Published Feb 24, 2022.
Settlement Jan 31, 2022
650,284 shares short
-105,876 shares (-14%) vs Jan 14, 2022
Published Feb 9, 2022.
Settlement Jan 14, 2022
756,160 shares short
-100,424 shares (-11.7%) vs Dec 31, 2021
Published Jan 25, 2022.
Settlement Dec 31, 2021
856,584 shares short
+92,334 shares (+12.1%) vs Dec 15, 2021
Published Jan 11, 2022.
Settlement Dec 15, 2021
764,250 shares short
-33,173 shares (-4.2%) vs Nov 30, 2021
Published Dec 24, 2021.
Settlement Nov 30, 2021
797,423 shares short
-56,792 shares (-6.6%) vs Nov 15, 2021
Published Dec 9, 2021.
Settlement Nov 15, 2021
854,215 shares short
+17,114 shares (+2%) vs Oct 29, 2021
Published Nov 24, 2021.
Settlement Oct 29, 2021
837,101 shares short
-68,452 shares (-7.6%) vs Oct 15, 2021
Published Nov 9, 2021.
Settlement Oct 15, 2021
905,553 shares short
-167,090 shares (-15.6%) vs Sep 30, 2021
Published Oct 26, 2021.
Settlement Sep 30, 2021
1,072,643 shares short
+152,096 shares (+16.5%) vs Sep 15, 2021
Published Oct 11, 2021.
Settlement Sep 15, 2021
920,547 shares short
-17,345 shares (-1.8%) vs Aug 31, 2021
Published Sep 24, 2021.
Settlement Aug 31, 2021
937,892 shares short
-51,930 shares (-5.2%) vs Aug 13, 2021
Published Sep 9, 2021.
Settlement Aug 13, 2021
989,822 shares short
-113,298 shares (-10.3%) vs Jul 30, 2021
Published Aug 24, 2021.
Settlement Jul 30, 2021
1,103,120 shares short
+157,630 shares (+16.7%) vs Jul 15, 2021
Published Aug 10, 2021.
Settlement Jul 15, 2021
945,490 shares short
-40,173 shares (-4.1%) vs Jun 30, 2021
Published Jul 26, 2021.
Settlement Jun 30, 2021
985,663 shares short
+43,431 shares (+4.6%) vs Jun 15, 2021
Published Jul 9, 2021.
Settlement Jun 15, 2021
942,232 shares short
-135,004 shares (-12.5%) vs May 14, 2021
Published Jun 24, 2021.
Settlement May 14, 2021
1,077,236 shares short
-3,104 shares (-0.3%) vs Apr 30, 2021
Published May 25, 2021.
Settlement Apr 30, 2021
1,080,340 shares short
-200,330 shares (-15.6%) vs Apr 15, 2021
Published May 11, 2021.
Settlement Apr 15, 2021
1,280,670 shares short
-292,677 shares (-18.6%) vs Mar 31, 2021
Published Apr 26, 2021.
Settlement Mar 31, 2021
1,573,347 shares short
+150,202 shares (+10.6%) vs Mar 15, 2021
Published Apr 9, 2021.
Settlement Mar 15, 2021
1,423,145 shares short
-275,204 shares (-16.2%) vs Feb 26, 2021
Published Mar 24, 2021.
Settlement Feb 26, 2021
1,698,349 shares short
-203,272 shares (-10.7%) vs Jan 29, 2021
Published Mar 9, 2021.
Settlement Jan 29, 2021
1,901,621 shares short
-180,673 shares (-8.7%) vs Jan 15, 2021
Published Feb 9, 2021.
Settlement Jan 15, 2021
2,082,294 shares short
Published Jan 26, 2021.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records. Adjusted prices exclude a reused ticker’s earlier issuer. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
Through Nov 13, 2026
Recorded amounts and dates, not confirmation of cash received.
View all 4 splits
| Ex-date | Event | Recorded detail |
|---|---|---|
| Feb 10, 2026 | Forward split | 1031 for 1000Each 1000 pre-split shares become 1031 post-split shares. |
| Jun 12, 2025 | Reverse split | 1 for 100Each 100 pre-split shares become 1 post-split share. |
| Jun 11, 2019 | Reverse split | 1 for 44Each 44 pre-split shares become 1 post-split share. |
| Aug 29, 2016 | Reverse split | 1 for 12Each 12 pre-split shares become 1 post-split share. |
Cash bars retain the event's recorded currency and share basis. The yield line divides recorded cash in the preceding 365 days, adjusted for intervening splits, by a verified raw close in the same currency. Special dividends are included. Future ex-dates are excluded from yield. A split changes share count, not investment value. For long shares, past entitlement depends on when you held them; short shares can create a dividend payment obligation.
Source: recorded cash-dividend and split events.
Portfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if AIM is in your portfolio and how much it contributes.
Sign inMarket context
Smart money context
Holder IQ: MEDIUM
14 smart-money holders: institutions with a high Holder IQ
Q1 2025, due May 15, 2025
Note: 13F filings are reported up to 45 days after quarter-end.Insider context
Sentiment: bullish
Last trade: buy 1 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 3
Moves the factor model did not explain
How much of AIM’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-13T15:43:43.117Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for AIM
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.